Micro-X Limited (MX1.AX)
AUD 0.08
(7.79%)
AUD 0.08
(7.79%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 4.05 Million AUD | -16.32% |
| 2023 | 4.76 Million AUD | -11.36% |
| 2022 | 5.37 Million AUD | -8.86% |
| 2021 | 5.9 Million AUD | -56.43% |
| 2020 | 13.54 Million AUD | 4.19% |
| 2019 | 13 Million AUD | 35.42% |
| 2018 | 9.6 Million AUD | 220.0% |
| 2017 | 3 Million AUD | 0.0% |
| 2016 | - AUD | -100.0% |
| 2015 | 15.41 Million AUD | 6377.3% |
| 2014 | 237.95 Thousand AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 4.4 Million AUD | 0.0% |
| 2024 Q4 | 4.05 Million AUD | 0.0% |
| 2024 FY | 4.05 Million AUD | -14.95% |
| 2023 FY | 4.76 Million AUD | -11.36% |
| 2023 Q4 | 4.76 Million AUD | 0.0% |
| 2023 Q2 | 5.06 Million AUD | 0.0% |
| 2022 Q4 | 5.37 Million AUD | 0.0% |
| 2022 FY | 5.37 Million AUD | -8.86% |
| 2022 Q2 | 5.63 Million AUD | 0.0% |
| 2021 FY | 5.9 Million AUD | -56.43% |
| 2021 Q4 | 5.9 Million AUD | 0.0% |
| 2021 Q2 | 13.94 Million AUD | 0.0% |
| 2020 Q2 | 12.64 Million AUD | 0.0% |
| 2020 FY | 13.54 Million AUD | 4.19% |
| 2020 Q4 | 13.54 Million AUD | 0.0% |
| 2019 Q2 | 6.75 Million AUD | 0.0% |
| 2019 Q4 | 13 Million AUD | 0.0% |
| 2019 FY | 13 Million AUD | 35.42% |
| 2018 Q2 | 3 Million AUD | 0.0% |
| 2018 FY | 9.6 Million AUD | 220.0% |
| 2018 Q4 | 9.6 Million AUD | 0.0% |
| 2017 Q2 | 2.8 Million AUD | 0.0% |
| 2017 Q4 | 3 Million AUD | 0.0% |
| 2017 FY | 3 Million AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 FY | - AUD | -100.0% |
| 2015 Q4 | 15.41 Million AUD | 0.0% |
| 2015 FY | 15.41 Million AUD | 6377.3% |
| 2015 Q3 | - AUD | 0.0% |
| 2014 FY | 237.95 Thousand AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| 4DMedical Limited | 5.12 Million AUD | 20.81% |
| Adherium Limited | 93.2 Thousand AUD | -4250.624% |
| Aroa Biosurgery Limited | 6.81 Million AUD | 40.514% |
| Atomo Diagnostics Limited | 84.67 Thousand AUD | -4689.18% |
| Anteris Technologies Ltd | 2.33 Million AUD | -73.818% |
| Control Bionics Limited | 961.73 Thousand AUD | -321.632% |
| CardieX Limited | 3.22 Million AUD | -25.629% |
| Compumedics Limited | 6.97 Million AUD | 41.88% |
| Cochlear Limited | 243.7 Million AUD | 98.336% |
| CleanSpace Holdings Limited | 3.44 Million AUD | -17.662% |
| Cyclopharm Limited | 4.22 Million AUD | 4.076% |
| EMVision Medical Devices Ltd | 2.9 Million AUD | -39.813% |
| Nova Eye Medical Limited | 3.34 Million AUD | -21.081% |
| HeraMED Limited | 260.65 Thousand AUD | -1455.69% |
| Imricor Medical Systems, Inc. | 15.7 Million AUD | 74.174% |
| ImpediMed Limited | 1.14 Million AUD | -254.768% |
| InhaleRx Limited | 560.27 Thousand AUD | -623.752% |
| LBT Innovations Limited | 1.74 Million AUD | -132.645% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | 70.67 Thousand AUD | -5637.773% |
| PolyNovo Limited | 15.38 Million AUD | 73.635% |
| Respiri Limited | 1.17 Million AUD | -244.648% |
| SomnoMed Limited | 1.01 Million AUD | -299.109% |
| Universal Biosensors, Inc. | 4.97 Million AUD | 18.435% |
| Uscom Limited | 989.27 Thousand AUD | -309.895% |
| Visioneering Technologies, Inc. | 312.15 Thousand AUD | -1199.03% |